PL421780A1 - Kompozycja żywieniowa dla pacjentów z odleżynami - Google Patents

Kompozycja żywieniowa dla pacjentów z odleżynami

Info

Publication number
PL421780A1
PL421780A1 PL421780A PL42178017A PL421780A1 PL 421780 A1 PL421780 A1 PL 421780A1 PL 421780 A PL421780 A PL 421780A PL 42178017 A PL42178017 A PL 42178017A PL 421780 A1 PL421780 A1 PL 421780A1
Authority
PL
Poland
Prior art keywords
patients
nutritional composition
pressure sores
amino acids
tryptophan
Prior art date
Application number
PL421780A
Other languages
English (en)
Other versions
PL235153B1 (pl
Inventor
Paweł Grieb
Tomasz Aleksander KRYCZKA
Original Assignee
Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia filed Critical Gbj Pharma Spolka Z Ograniczona Odpowiedzialnoscia
Priority to PL421780A priority Critical patent/PL235153B1/pl
Priority to PCT/IB2018/053794 priority patent/WO2018220518A1/en
Priority to EP18739924.1A priority patent/EP3629771B1/en
Priority to ES18739924T priority patent/ES3060235T3/es
Publication of PL421780A1 publication Critical patent/PL421780A1/pl
Publication of PL235153B1 publication Critical patent/PL235153B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja żywieniowa, korzystnie w postaci o zmodyfikowanym uwalnianiu, do zastosowania doustnego w suplementacji aminokwasów u pacjentów, w celu leczenia i/lub zapobiegania powstawaniu odleżyn, która jako substancję czynną zawiera aminokwasy alaninę, histydynę, treoninę i tryptofan, korzystniej L-karnozynę jako źródło alaniny i histydyny oraz treoninę i tryptofan, przy czym korzystnie kompozycja żywieniowa jest do zastosowania w suplementacji pacjentów aminokwasami w celu leczenia i/lub zapobiegania powstawaniu odleżyn u pacjentów z przeciwwskazaniem do stosowania diety wysokobiałkowej.
PL421780A 2017-06-02 2017-06-02 Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami PL235153B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL421780A PL235153B1 (pl) 2017-06-02 2017-06-02 Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami
PCT/IB2018/053794 WO2018220518A1 (en) 2017-06-02 2018-05-29 A nutritional composition intended for patients with pressure ulcers
EP18739924.1A EP3629771B1 (en) 2017-06-02 2018-05-29 An oral nutritional composition for use in the treatment and/or prevention of pressure ulcers
ES18739924T ES3060235T3 (en) 2017-06-02 2018-05-29 An oral nutritional composition for use in the treatment and/or prevention of pressure ulcers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL421780A PL235153B1 (pl) 2017-06-02 2017-06-02 Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami

Publications (2)

Publication Number Publication Date
PL421780A1 true PL421780A1 (pl) 2018-12-03
PL235153B1 PL235153B1 (pl) 2020-06-01

Family

ID=64456164

Family Applications (1)

Application Number Title Priority Date Filing Date
PL421780A PL235153B1 (pl) 2017-06-02 2017-06-02 Farmaceutyczna kompozycja żywieniowa dla pacjentów z odleżynami

Country Status (4)

Country Link
EP (1) EP3629771B1 (pl)
ES (1) ES3060235T3 (pl)
PL (1) PL235153B1 (pl)
WO (1) WO2018220518A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4128524B2 (ja) * 2001-06-08 2008-07-30 独立行政法人理化学研究所 体温上昇性アミノ酸群飲食用及び医療用の剤
US7318934B2 (en) * 2002-10-29 2008-01-15 Medical Nutrition Usa, Inc. Method for treating wounds to promote healing
CA2858471C (en) * 2011-12-15 2020-10-13 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
BR112014014147B1 (pt) * 2011-12-15 2020-05-05 Société des Produits Nestlé S.A. produto nutricional, método para sua fabricação, e usos de uma solução aquosa de um biopolímero de grau alimentício.
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
AU2015294059B2 (en) * 2014-07-21 2019-03-14 Société des Produits Nestlé S.A. Nutritional products to promote safe swallowing for individuals with dysphagia

Also Published As

Publication number Publication date
WO2018220518A1 (en) 2018-12-06
EP3629771C0 (en) 2025-12-10
EP3629771B1 (en) 2025-12-10
ES3060235T3 (en) 2026-03-25
PL235153B1 (pl) 2020-06-01
EP3629771A1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
BR112017009405A2 (pt) composições antibióticas.
BR112015019064A2 (pt) métodos de tratamento de melanoma
MX2021000388A (es) Suplemento alimenticio.
EP4674433A3 (en) Pulsatile drug delivery system for treating morning akinesia
MX2011013126A (es) Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos.
CO6541625A2 (es) Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados de los mismos para la inducción de tolerancia
MX2019001903A (es) Composiciones y metodos para modular la microflora gastrointestinal en un canino.
PH12020551500A1 (en) Viscosity reduction of highly concentrated protein formulations
BR112018072064B8 (pt) Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação
EP4218809A3 (en) Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
MA39157A1 (fr) Composition utile pour favoriser la fertilite feminine
MY183250A (en) Pediatric nutritional composition with milk peptides for healthy growth and development
MX2019008589A (es) Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial.
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
PH12018500089A1 (en) Nutritional compositions comprising hydrolysed casein
MY187022A (en) Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
MX2015001019A (es) Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.
PL421780A1 (pl) Kompozycja żywieniowa dla pacjentów z odleżynami
NZ728962A (en) Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia
PL420267A1 (pl) Ekstrakt z grzyba poliporoidalnego, kompozycja zawierająca ten ekstrakt oraz jego zastosowanie
PL420907A1 (pl) Kompozycja w postaci żelu
PL437784A1 (pl) Peptyd rozkładający kryształy pirofosforanu wapnia do zastosowania jako lek przeciwko dnie rzekomej